XML 23 R7.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities    
Net loss $ (179,329) $ (34,804)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities    
Depreciation and amortization 1,623 6,932
Stock-based compensation expense 4,223 15,269
Earnings in equity method investment (93,390) 0
Cash receipts from Holdings 21,659 0
Amortization of deferred financing costs 74 958
Loss on extinguishment of debt 0 148
Revaluation of earnout consideration liability 57,101 34,060
Revaluation of warrant liability 152,782 76,211
Change in fair value of derivative liability 0 (425)
Non-cash operating lease expense 405 1,752
Deferred tax benefit (1,837) (3,510)
Changes in assets and liabilities:    
Accounts receivable 2,063 (3,311)
Inventories (5,195) (2,550)
Prepaid expenses and other assets (3,256) (115)
Accounts payable (29) 4,499
Accrued expenses 38,230 1,487
Lease liabilities (369) (1,828)
Other liabilities (3,648) 666
Net cash (used in ) provided by operating activities (8,893) 95,439
Cash flows from investing activities    
Purchase of property and equipment 0 (4,782)
Holdings cash deconsolidated as a result of the Management Agreement (50,303) 0
Resolute Holdings cash deconsolidated as a result of the Spin-Off (10,000) 0
Capitalized software expenditures (387) (729)
Net cash used in investing activities (60,690) (5,511)
Cash flows from financing activities    
Proceeds from employee stock purchase plan and exercise of options 121 2,895
Payments for taxes related to net share settlement of equity awards and earnout liability (18,011) (8,482)
Payment of term loan 0 (10,333)
Purchase of treasury shares (12,247) 0
Deferred finance costs related to debt modification 0 (1,889)
Payment of tax receivable agreement liability (4,735) (1,303)
Distributions to non-controlling members 0 (34,863)
Special distribution to non-controlling members 0 (15,573)
Dividend to Class A shareholders 0 (8,922)
Proceeds from the exercise of warrants 154,356 0
Net cash provided by (used in) financing activities 119,484 (78,470)
Net increase in cash and cash equivalents 49,901 11,458
Cash and cash equivalents, beginning of period 77,461 41,216
Cash and cash equivalents, end of period 127,362 52,674
Supplemental disclosure of cash flow information:    
Cash paid for interest 2,164 16,987
Cash paid for income taxes 16,770 3,420
Supplemental disclosure of non-cash operating and financing activities:    
Operating lease ROU assets exchanged for lease liabilities 4,224 0
Derivative asset - interest rate swap (502) (2,422)
Non-cash portion of warrant exercise (215,586) 0
Settlement of earnout phase two (77,634) 0
Contribution to Holdings for share-based compensation 12,565 0
Holdings net liabilities, excluding cash and cash equivalent, deconsolidated as a result of Management Agreement (98,508) 0
Resolute Holdings net liabilities, excluding cash and cash equivalent, deconsolidated as a result of Spin-Off $ (1,542) $ 0